Kailera Therapeutics logo

Kailera Therapeutics

Waltham, MA

Kailera Therapeutics is a clinical-stage biotechnology company that provides revolutionary therapies for treating obesity and related diseases.

kailera.com

Company Details

Founded

2024

Employees

Between 50 - 200 employees

Raised

$1,000,000,000

Headquarters Location

Waltham, MA

Public

No

Acquired

No

CEO

Ron RenaudRon Renaud

Founders

Ron Renaud
Ron Renaud

Company Collections

These are collections Kailera Therapeutics is a part of. Click on the collection name to view similar companies.

Kailera Therapeutics' Industries

Kailera Therapeutics Headquarters Location

890 Winter Street Suite 220, Waltham, MA 02451

Total Amount Raised: $1,000,000,000

Kailera Therapeutics Funding Rounds

  • Series B

    $600,000,000

    Series B Investors

    Bain Capital Private Equity (Europe)
    Janus Henderson Investors
    RTW Investments
    Atlas Venture
    Bain Capital Life Sciences Fund
    Sirona Capital
    Surveyor Capital
    Adage Capital Management
    Invus Group
    Royalty Pharma
    T. Rowe Price
    Perseverance Capital Management
    Qatar Investment Authority
    CPP Investment Board

  • Series A

    $400,000,000

    Series A Investors

    Atlas Venture
    Bain Capital Life Sciences Fund
    RTW Investments
    Lyra Capital
Funding info provided by Diffbot.

Kailera Therapeutics Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Kailera Therapeutics.

Recent reviews